文献速递心律失常血脂与心血管预防

心房颤动发作与缺血性卒中风险的时间关联

Temporal Association Between Episodes of Atrial Fibrillation and Risk of Ischemic Stroke.
PubMed 文献 · JAMA Cardiol · 2021-01-01

本研究为病例交叉研究,纳入891例植入心脏电子设备且卒中前120天连续心律监测的缺血性卒中患者,分析房颤发作(每日≥5.5小时)与卒中的时间关联。结果显示,与对照期相比,病例期房颤≥5.5小时的OR为3.71(95%CI 2.06-6.70),卒中风险在房颤发作后1-5天最高(OR 5.00;95%CI 2.62-9.55),随后迅速下降。结论支持房颤短暂直接增加卒中风险,为限时抗凝试验提供依据。

要点

  • 房颤发作≥5.5小时与卒中风险增加相关,OR 3.71。
  • 卒中风险在房颤发作后1-5天最高,OR 5.00。
  • 单日房颤>23小时与卒中风险增加最明显,OR 5.00。

核心结论

  • 在植入心脏电子设备且卒中前连续监测心律的患者中,房颤发作≥5.5小时与缺血性卒中风险短暂升高相关,风险在发作后5天内最高并迅速下降。

研究设计与样本

  • 病例交叉研究,纳入891例植入心脏电子设备、发生缺血性卒中且卒中前120天有连续远程心律监测的患者。

主要发现

  • 891例患者中,575例(64.5%)为男性,中位年龄76岁(IQR 67-82)。
  • 66例患者存在不一致的心律状态,其中52例在病例期房颤≥5.5小时,14例在对照期,OR 3.71(95%CI 2.06-6.70)。
  • 卒中风险在房颤发作后1-5天最高,OR 5.00(95%CI 2.62-9.55)。
  • 单日房颤>23小时与卒中风险增加最明显,OR 5.00(95%CI 2.08-12.01)。

关键数值与推荐

  • 房颤暴露定义为任意一天房颤持续时间≥5.5小时,比较卒中前1-30天与91-120天。

临床怎么用

  • 对于植入心脏电子设备且监测到多发数小时房颤发作的患者,可考虑在发作后短期内加强抗凝管理。
  • 研究结果支持开展限时抗凝治疗临床试验,针对不频繁的多小时房颤发作患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Understanding the temporal association between atrial fibrillation (AF) and ischemic stroke informs our understanding of the AF-stroke mechanism and treatment of paroxysmal AF. OBJECTIVE: To define the temporal association between episodes of AF and stroke in patients with cardiac implantable electronic devices (CIEDs). DESIGN, SETTING, AND PARTICIPANTS: In this case-crossover study, data from a large national electronic health record database were linked with a single-vendor database of heart rhythm records of patients with CIEDs capable of continuous heart rhythm monitoring. Patients with CIEDs who sustained an ischemic stroke who also had 120 days of continuous remote rhythm monitoring prestroke were included. Data were collected from January 2007 to March 2017, and data were analyzed from November 2019 to June 2020. EXPOSURE: AF for 5.5 hours or more on any given day during days 1 to 30 vs days 91 to 120 prestroke. MAIN OUTCOMES AND MEASURES: Odds ratio for stroke comparing AF during days 1 to 30 vs 91 to 120 prestroke. This analysis was planned prior to the study. RESULTS: From 466 635 patients included in both the Optum electronic health record and CareLink databases, 891 patients with CIEDs and ischemic stroke with continuous monitoring in the 120 days prestroke were identified. Of 891 included patients, 575 (64.5%) were male, and the median (interquartile range) age was 76 (67-82) years. The vast majority of patients with stroke had either no AF meeting the threshold duration of 5.5 hours or more in both the case and control periods (682 of 891 [76.5%]) or AF of 5.5 hours or more in both periods (143 of 891 [16.0%]). For those not meeting the 5.5-hour AF threshold in either period, there was no or very little AF throughout the 120 days prestroke. A total of 66 patients had informative, discordant arrhythmic states, with 52 having AF of 5.5 hours or more in the case period vs 14 in the control period (odds ratio [OR], 3.71; 95% CI, 2.06-6.70). Stroke risk was increased most in days 1 to 5 following an AF episode (OR, 5.00; 95% CI, 2.62-9.55). AF greater than 23 hours on a given day was associated with the clearest increase in stroke risk (OR, 5.00; 95% CI, 2.08-12.01). CONCLUSIONS AND RELEVANCE: In this large cohort of patients with CIEDs and continuous rhythm monitoring prior to ischemic stroke, excess stroke risk above baseline was highest within 5 days of an episode of AF of 5.5 hours or more in duration and diminished rapidly thereafter. Our findings are consistent with the traditional view that AF is directly and transiently associated with ischemic stroke. These results provide support for trials of time-delimited anticoagulation for patients with infrequent multihour episodes of AF and rigorous, continuous rhythm monitoring.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Singer DE, Ziegler PD, Koehler JL, et al. Temporal Association Between Episodes of Atrial Fibrillation and Risk of Ischemic Stroke. JAMA Cardiol. 2021. PMID: 34586356. doi:10.1001/jamacardio.2021.3702

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。